(VRSK) Verisk Analytics - Ratings and Ratios
Data Analytics, Insurance Solutions, Underwriting, Claims, Risk Management
VRSK EPS (Earnings per Share)
VRSK Revenue
Description: VRSK Verisk Analytics
Verisk Analytics Inc. is a leading provider of data analytics and technology solutions to the insurance industry globally. The companys comprehensive suite of services includes underwriting solutions, claims insurance solutions, and anti-fraud solutions, catering to various aspects of the insurance value chain.
Key to Verisks success is its ability to provide actionable insights and data-driven solutions that enhance risk assessment, policy administration, and claims processing for insurers. Their underwriting solutions, for instance, offer policy language, prospective loss costs, and underwriting rules, while their claims solutions provide property estimating and casualty claims decision support.
From a financial perspective, Verisk has demonstrated a strong track record of growth, driven by its diversified portfolio of services and robust demand from the insurance industry. Key performance indicators (KPIs) such as revenue growth rate, EBITDA margin, and return on equity (ROE) are crucial in evaluating the companys financial health. With a ROE of 407.47%, Verisk exhibits exceptional profitability. Additionally, the companys ability to generate consistent cash flows and maintain a healthy debt-to-equity ratio is vital for its continued investment in research and development, driving innovation and expansion into new markets.
Verisks competitive edge lies in its extensive data assets, advanced analytics capabilities, and deep understanding of the insurance industry. The companys catastrophe modeling solutions, for example, provide insurers with critical insights into potential losses from extreme events, enabling them to make informed underwriting decisions. As the insurance landscape continues to evolve, Verisk is well-positioned to capitalize on emerging trends, such as the increasing use of data analytics and technology in insurance underwriting and claims processing.
To further assess Verisks investment potential, it is essential to monitor its valuation multiples, such as the price-to-earnings (P/E) ratio, which currently stands at 45.08. Comparing this to industry peers and the broader market can provide insights into the companys relative attractiveness. Moreover, tracking Verisks support and resistance levels, as indicated by its technical analysis, can help investors identify potential entry and exit points.
VRSK Stock Overview
| Market Cap in USD | 37,536m |
| Sub-Industry | Research & Consulting Services |
| IPO / Inception | 2009-10-07 |
VRSK Stock Ratings
| Growth Rating | 52.7% |
| Fundamental | 83.7% |
| Dividend Rating | 57.6% |
| Return 12m vs S&P 500 | -19.9% |
| Analyst Rating | 3.39 of 5 |
VRSK Dividends
| Dividend Yield 12m | 0.63% |
| Yield on Cost 5y | 0.97% |
| Annual Growth 5y | 7.63% |
| Payout Consistency | 100.0% |
| Payout Ratio | 25.3% |
VRSK Growth Ratios
| Growth Correlation 3m | -86.2% |
| Growth Correlation 12m | 35.2% |
| Growth Correlation 5y | 82.1% |
| CAGR 5y | 12.26% |
| CAGR/Max DD 3y | 0.60 |
| CAGR/Mean DD 3y | 3.60 |
| Sharpe Ratio 12m | -0.41 |
| Alpha | -19.83 |
| Beta | 0.621 |
| Volatility | 23.36% |
| Current Volume | 1402.2k |
| Average Volume 20d | 954.2k |
| Stop Loss | 247.4 (-3%) |
| Signal | -0.67 |
Piotroski VR‑10 (Strict, 0-10) 9.0
| Net Income (915.9m TTM) > 0 and > 6% of Revenue (6% = 179.2m TTM) |
| FCFTA 0.21 (>2.0%) and ΔFCFTA 3.01pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 16.01% (prev -2.31%; Δ 18.31pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.26 (>3.0%) and CFO 1.24b > Net Income 915.9m (YES >=105%, WARN >=100%) |
| Net Debt (2.80b) to EBITDA (1.64b) ratio: 1.71 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.53 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (140.3m) change vs 12m ago -2.06% (target <= -2.0% for YES) |
| Gross Margin 69.39% (prev 67.91%; Δ 1.48pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 62.46% (prev 58.21%; Δ 4.25pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 9.56 (EBITDA TTM 1.64b / Interest Expense TTM 138.4m) >= 6 (WARN >= 3) |
Altman Z'' 9.41
| (A) 0.10 = (Total Current Assets 1.38b - Total Current Liabilities 899.4m) / Total Assets 4.79b |
| (B) 1.57 = Retained Earnings (Balance) 7.51b / Total Assets 4.79b |
| warn (B) unusual magnitude: 1.57 — check mapping/units |
| (C) 0.28 = EBIT TTM 1.32b / Avg Total Assets 4.78b |
| (D) 1.70 = Book Value of Equity 7.63b / Total Liabilities 4.48b |
| Total Rating: 9.41 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 83.72
| 1. Piotroski 9.0pt = 4.0 |
| 2. FCF Yield 2.54% = 1.27 |
| 3. FCF Margin 34.17% = 7.50 |
| 4. Debt/Equity 10.45 = -2.50 |
| 5. Debt/Ebitda 1.98 = 0.03 |
| 6. ROIC - WACC 21.97% = 12.50 |
| 7. RoE 439.1% = 2.50 |
| 8. Rev. Trend 56.58% = 4.24 |
| 9. EPS Trend 83.58% = 4.18 |
What is the price of VRSK shares?
Over the past week, the price has changed by -6.41%, over one month by -4.61%, over three months by -17.43% and over the past year by -4.74%.
Is Verisk Analytics a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of VRSK is around 238.61 USD . This means that VRSK is currently overvalued and has a potential downside of -6.46%.
Is VRSK a buy, sell or hold?
- Strong Buy: 3
- Buy: 3
- Hold: 10
- Sell: 2
- Strong Sell: 0
What are the forecasts/targets for the VRSK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 307.3 | 20.5% |
| Analysts Target Price | 307.3 | 20.5% |
| ValueRay Target Price | 264.1 | 3.6% |
Last update: 2025-09-11 04:52
VRSK Fundamental Data Overview
CCE Cash And Equivalents = 628.7m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 41.6527
P/E Forward = 35.461
P/S = 12.5685
P/B = 122.3817
P/EG = 3.3714
Beta = 0.862
Revenue TTM = 2.99b USD
EBIT TTM = 1.32b USD
EBITDA TTM = 1.64b USD
Long Term Debt = 3.21b USD (from longTermDebt, last quarter)
Short Term Debt = 44.8m USD (from shortTermDebt, last quarter)
Debt = 3.26b USD (Calculated: Short Term 44.8m + Long Term 3.21b)
Net Debt = 2.80b USD (from netDebt column, last quarter)
Enterprise Value = 40.17b USD (37.54b + Debt 3.26b - CCE 628.7m)
Interest Coverage Ratio = 9.56 (Ebit TTM 1.32b / Interest Expense TTM 138.4m)
FCF Yield = 2.54% (FCF TTM 1.02b / Enterprise Value 40.17b)
FCF Margin = 34.17% (FCF TTM 1.02b / Revenue TTM 2.99b)
Net Margin = 30.67% (Net Income TTM 915.9m / Revenue TTM 2.99b)
Gross Margin = 69.39% ((Revenue TTM 2.99b - Cost of Revenue TTM 914.2m) / Revenue TTM)
Tobins Q-Ratio = 5.26 (Enterprise Value 40.17b / Book Value Of Equity 7.63b)
Interest Expense / Debt = 1.09% (Interest Expense 35.5m / Debt 3.26b)
Taxrate = 22.62% (277.9m / 1.23b)
NOPAT = 1.02b (EBIT 1.32b * (1 - 22.62%))
Current Ratio = 1.53 (Total Current Assets 1.38b / Total Current Liabilities 899.4m)
Debt / Equity = 10.45 (Debt 3.26b / last Quarter total Stockholder Equity 311.7m)
Debt / EBITDA = 1.98 (Net Debt 2.80b / EBITDA 1.64b)
Debt / FCF = 3.19 (Debt 3.26b / FCF TTM 1.02b)
Total Stockholder Equity = 208.6m (last 4 quarters mean)
RoA = 19.10% (Net Income 915.9m, Total Assets 4.79b )
RoE = 439.1% (Net Income TTM 915.9m / Total Stockholder Equity 208.6m)
RoCE = 38.67% (Ebit 1.32b / (Equity 208.6m + L.T.Debt 3.21b))
RoIC = 29.68% (NOPAT 1.02b / Invested Capital 3.45b)
WACC = 7.70% (E(37.54b)/V(40.79b) * Re(8.30%)) + (D(3.26b)/V(40.79b) * Rd(1.09%) * (1-Tc(0.23)))
Shares Correlation 3-Years: -96.97 | Cagr: -1.07%
Discount Rate = 8.30% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 78.73% ; FCFE base≈960.8m ; Y1≈1.06b ; Y5≈1.35b
Fair Price DCF = 160.5 (DCF Value 22.42b / Shares Outstanding 139.7m; 5y FCF grow 11.34% → 3.0% )
EPS Correlation: 83.58 | EPS CAGR: 9.63% | SUE: 2.22 | # QB: True
Revenue Correlation: 56.58 | Revenue CAGR: 8.97%
Additional Sources for VRSK Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle